- Home
- XTNT vs FSEA Comparison
XTNT vs FSEA Comparison
Compare XTNT & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- FSEA
- Stock Information
- Founded
- XTNT N/A
- FSEA 1890
- Country
- XTNT United States
- FSEA United States
- Employees
- XTNT N/A
- FSEA N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- FSEA Savings Institutions
- Sector
- XTNT Health Care
- FSEA Finance
- Exchange
- XTNT Nasdaq
- FSEA Nasdaq
- Market Cap
- XTNT 60.9M
- FSEA 52.1M
- IPO Year
- XTNT N/A
- FSEA N/A
- Fundamental
- Price
- XTNT $0.45
- FSEA $10.85
- Analyst Decision
- XTNT Strong Buy
- FSEA
- Analyst Count
- XTNT 1
- FSEA 0
- Target Price
- XTNT $3.00
- FSEA N/A
- AVG Volume (30 Days)
- XTNT 66.0K
- FSEA 13.4K
- Earning Date
- XTNT 05-14-2025
- FSEA 05-09-2025
- Dividend Yield
- XTNT N/A
- FSEA N/A
- EPS Growth
- XTNT N/A
- FSEA N/A
- EPS
- XTNT N/A
- FSEA N/A
- Revenue
- XTNT $117,267,000.00
- FSEA $15,874,000.00
- Revenue This Year
- XTNT $15.56
- FSEA N/A
- Revenue Next Year
- XTNT $22.39
- FSEA N/A
- P/E Ratio
- XTNT N/A
- FSEA N/A
- Revenue Growth
- XTNT 28.44
- FSEA 70.41
- 52 Week Low
- XTNT $0.33
- FSEA $8.30
- 52 Week High
- XTNT $0.97
- FSEA $11.69
- Technical
- Relative Strength Index (RSI)
- XTNT 49.25
- FSEA 44.13
- Support Level
- XTNT $0.34
- FSEA $10.80
- Resistance Level
- XTNT $0.43
- FSEA $11.18
- Average True Range (ATR)
- XTNT 0.05
- FSEA 0.34
- MACD
- XTNT 0.01
- FSEA -0.05
- Stochastic Oscillator
- XTNT 68.75
- FSEA 44.44
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.